Anna Koumarianou

Chief Consultant Medical Oncologist

University General Hospital Attikon

Greece

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Anna Koumarianou is a Chief Consultant Medical Oncologist at the University General Hospital Attikon in Greece. Her research focuses on real-world studies regarding breast cancer treatments, immune checkpoint inhibitors in sarcomas, and the molecular alterations in ovarian tumors. She has contributed significantly to the field with recent articles addressing the effectiveness and safety of various oncological therapies and guidelines for the management of neuroendocrine tumors.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (5)

Beata Kos-Kudła

Chair/Professor of Medicine

Medical University of Silesia

POLAND

View details

Helen Gogas

Head, Professor in Medical Oncology,

National and Kapodistrian University of Athens

GREECE

View details

Louis de Mestier

FRANCE

View details

Dionysios Papachristou

Professor, Lab Director

University of Patras

GREECE

View details

Michalis Liontos

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Koumarianou

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study

Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study

Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation

Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy

The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers

Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy

Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction

European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours

Collaborators (5)

Beata Kos-Kudła

Helen Gogas

Louis de Mestier

Dionysios Papachristou

Michalis Liontos

Make your next move.